Sequins

📍 Sydney, Australia👥 16 employees💰 Last funded Oct 2022
Biotechnology🌐 sequins.bio
Website LinkedIn
Sequins (sequencing spike-ins) are synthetic nucleic acid controls that directly mirror naturally occurring sequences. Our innovative design enables representation of almost any genomic feature, in any organism with a reference genome. Sequins retain the same nucleotide composition as the natural sequence and enable accurate representation of genomic complexity without compromising integrity of samples and results.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
United States
1
Frequently asked questions
Who invested in Sequins?
Sequins has 2 investors on record on gritt.io.
When did Sequins last raise funding?
The most recent investment in Sequins recorded on gritt.io was in October 2022.
What industry is Sequins in?
Sequins operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Sequins based?
Sequins is headquartered in Sydney, Australia.